YourChoice Therapeutics is an early-stage biopharmaceutical company based in San Francisco. The company is dedicated to developing the first hormone-free birth control pill for men. Their lead candidate, YCT-529, is currently undergoing a phase one clinical trial. In preclinical studies, YCT-529 demonstrated efficacy comparable to or better than traditional female birth control pills. YourChoice Therapeutics aims to apply its ...
YourChoice Therapeutics is an early-stage biopharmaceutical company based in San Francisco. The company is dedicated to developing the first hormone-free birth control pill for men. Their lead candidate, YCT-529, is currently undergoing a phase one clinical trial. In preclinical studies, YCT-529 demonstrated efficacy comparable to or better than traditional female birth control pills. YourChoice Therapeutics aims to apply its patented therapeutic platform to develop hormone-free family planning products for women in future programs. The company was established in 2018 and received a $15 million Series A investment in 2022.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.